Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: A qualitative investigation

Microscopy Research and Technique

Volumn 77, Issue 8, 2014, Pages 594-601

  Swanepoel, Albe C ^a   Lindeque, Barend G ^a   Swart, Paul J ^a   Abdool, Zeelha ^a   Pretorius, Etheresia ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Electron microscopy; Estrogen; Fibrin network; Menstrual cycle; Morphology

Indexed keywords

BLOOD; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MORPHOLOGY; SCANNING ELECTRON MICROSCOPY;

BLOOD PLASMA; ELECTRON MICROSCOPY ANALYSIS; FIBER MORPHOLOGY; FIBRIN NETWORK; LEVEL CHANGE; MENSTRUAL CYCLE; OESTROGENS; PLASMA FIBRINOGEN LEVELS; SCANNING AND TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURAL CHANGES;

FIBERS;

ESTROGEN; FIBRIN;

BLOOD; FEMALE; HUMAN; MENSTRUAL CYCLE; METABOLISM; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ESTROGENS; FEMALE; FIBRIN; HUMANS; MENSTRUAL CYCLE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 84904470952     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.22378     Document Type: Article

References (28)

1. Ariëns RAS, Kohler HP, Mansfield MW, Grant PW. 1999. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 19:2012-2016.
2. Bailey AL, Scantlebury DC, Smyth SS. 2009. Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol 29:284-288.
3. Butenas S, Mann K. 2002. Blood coagulation. Biochemistry (Moscow) 67:3-12.
4. Dighe AS, Moy JM, Hayes FJ, Sluss PM. 2005. High-resolution reference ranges for estradiol, luteinizing hormone, and follicle-stimulating hormone in men and women using the AxSYM assay system. Clin Biochem 38:175-179.
5. Eliasson M, Evrinb PE, Lundblada D, Asplundc K, Rånbyd M. 1993. Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen: A population study. Fibrinolysis 7:316-323.
6. Giardina E-GV, Chen HJ, Sciacca RR, Rabbani LE. 2004. Dynamic variability of hemostatic and fibrinolytic factors in young women. J Clin Endocrinol Metab 89:6179-6184.
7. Herd C, Page C. 1994. Pulmonary immune cells in health and disease: Platelets. Eur Respir J 7:1145-1160.
8. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. 1999. Variations in coagulation factors in women: Effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 82:1456-1461.
9. Kan WH, Hsu JT, Schwacha MG, Choudhry, MA, Bland KI, Chaudry IH. 2008. Estrogen ameliorates trauma-hemorrhage-induced lung injury via endothelial nitric oxide synthase-dependent activation of protein kinase G. Ann Surg 248:294-302.
10. Knobil E, Neill JD, Adashi EY. 1998. Encyclopedia of reproduction. San Diego: Academic Press.
11. Leng X-H, Hong SY, Larrucea S, Zhang W, Li T-T, López JA, Bray PF. 2004. Platelets of female mice are intrinsically more sensitive to agonists than are platelets of males. Arterioscler Thromb Vasc Biol 24:376-381.
12. Liao S-L, Chen W-Y, Kuo J-S, Chen C-J. 2001. Association of serum estrogen level and ischemic neuroprotection in female rats. Neurosci Lett 297:159-162.
13. Lowe GD, Rumley A, Mackie IJ. 2004. Plasma fibrinogen. Ann Clin Biochem 41:430-440.
14. Knol HM, Kemperman RFJ, Kluin-Nelemans HC, Mulder AB, Meijer K. 2012. Haemostatic variables during normal menstrual cycle: A systematic review. Thromb Haemost 107:22-29.
15. Mosesson M. 2005. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3:1894-1904.
16. Nielsen VG, Gurley WQ Jr, Burch TM. 2004. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 99:120-123.
17. Niswender G, Nett T. 1994. Corpus luteum and its control in infraprimate species. Physiol Reprod 1:781-816.
18. O'Riordan MN, Higgins JR. 2003. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 17:385-396.
19. Roeloffzen WWH, Kluin-Nelemans HC, Mulder AB, Veeger NJGM, Bosman L, de Wolf JTM. 2010. In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg 110:987-994.
20. Roof RL, Hall ED. 2000. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 17:367-388.
21. Schroeder V, Chatterjee T, Kohler H. 2001. Influence of blood coagulation factor XIII and FXIII val34leu on plasma clot formation measured by thrombelastography. Thromb Res 104:467-474.
22. Silverthorn DU, Ober WC, Garrison CW, Silverthorn AC, Johnson BR. 2009. Human physiology: An integrated approach. Cummings: Pearson/Benjamin.
23. Suzuki S, Brown CM, Wise PM. 2009. Neuroprotective effects of estrogens following ischemic stroke. Front Neuroendocrinol 30:201-211.
24. Trigg DE, Wood MG, Kouides PA, Kadir RA, Cordle E, Govind A, Lu Y, Wang S, Sullivan-Halley J, Chang E. 2011. Hormonal influences on hemostasis in women. Sem Thromb Hemost 37:77-86.
25. Tyler HM. 1969. Fibrin crosslinking demonstrated by thrombelastography. Thromb Diath Haemorrh 22:398-400.
26. van der Spuy WJ, Pretorius E. 2012. Interrelation between inflammation, thrombosis, and neuroprotection in cerebral ischemia. Rev Neurosci 23:269-278.
27. Wong JH, Dukes J, Levy RE, Sos B, Mason SE, Fong TS, Weiss EJ. 2008. Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns. J Clin Investig 118:2969.
28. Yu HP, Hsieh YC, Suzuki T, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH. 2007. The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage. Ann Surg 245:971-977.